The effect of purification of Ga-68-labeled exendin on in vivo distribution.

Autor: Brom M; Department of Radiology and Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. maarten.brom@radboudumc.nl., Franssen GM; Department of Radiology and Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Joosten L; Department of Radiology and Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Gotthardt M; Department of Radiology and Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
Jazyk: angličtina
Zdroj: EJNMMI research [EJNMMI Res] 2016 Dec; Vol. 6 (1), pp. 65. Date of Electronic Publication: 2016 Aug 12.
DOI: 10.1186/s13550-016-0221-8
Abstrakt: Background: Ga-labeled radiotracers are increasingly used for PET imaging. During the labeling procedure, formation of (68)Ga-colloid may occur. Upon i.v. injection, (68)Ga-colloid will accumulate rapidly in the liver, spleen, and bone marrow, resulting in reduced target-to-background ratios. In this study, we applied a thin layer chromatography (TLC) method to measure colloid content and we studied the effect of the purification method on the in vivo characteristics of (68)Ga-labeled DOTA-exendin-3. DOTA-exendin-3 was labeled with (68)Ga, and the colloid content was measured by TLC on silica gel ITLC with two mobile phases. The labeling mixture was purified by gel filtration on a 5-ml G25M column, by reversed-phase high-performance liquid chromatography (RP-HPLC) using a C8 column or by solid phase extraction (SPE) on an HLB cartridge. The in vivo characteristics of the preparations were determined in BALB/c nude mice, and PET images were acquired 1 h p.i. using a microPET scanner. In these studies, unpurified (68)Ga-DOTA-exendin-3 and (111)In-DOTA-exendin-3 were used as a reference.
Results: The colloid content of (111)In-DOTA-exendin-3 and unpurified, gel filtration, RP-HPLC- and SPE-purified (68)Ga-DOTA exendin-3 was <3, 7, 9, <3, and <3 %, respectively. Unpurified (68)Ga-DOTA exendin-3 showed high liver and spleen uptake. Gel filtration partly removed (68)Ga-colloid from the preparation, resulting in moderate liver and spleen SPE-purified (68)Ga-DOTA exendin-3 showed very low liver and spleen uptake, that was similar to that of RP-HPLC purified (68)Ga-DOTA exendin-3.
Conclusions: We showed that the colloid content can be measured by TLC and that solid phase extraction and HPLC completely remove (68)Ga-colloid from (68)Ga-labeled tracer preparations, resulting in very low liver and spleen uptake. This study clearly shows the importance of removal of (68)Ga-colloid from preparations.
Databáze: MEDLINE
Externí odkaz: